Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Ji, Li Nong ^a   Lu, Ju Ming ^b   Guo, Xiao Hui ^c   Yang, Wen Ying ^d   Weng, Jian Ping ^e   Jia, Wei Ping ^f   Zou, Da Jin ^g   Zhou, Zhi Guang ^h   Yu, De Min ⁱ   Liu, Jie ^j   Shan, Zhong Yan ^k   Yang, Yu Zhi ^l   Hu, Ren Ming ^m   Zhu, Da Long ⁿ   Yang, Li Yong ^o   Chen, Li ^p   Zhao, Zhi Gang ^q   Li, Qi Fu ^r   Tian, Hao Ming ^s   Ji, Qiu He ^t   Liu, Jing ^u   Ge, Jia Pu ^v   Shi, Li Xin ^w   Xu, Yan Cheng ^x   more..

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^e THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^f SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^g SECOND MILITARY MEDICAL UNIVERSITY   (China)

^h CENTRAL SOUTH UNIVERSITY   (China)

ⁱ TIANJIN MEDICAL UNIVERSITY   (China)

^j SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^k CHINA MEDICAL UNIVERSITY   (China)

^l Heilongjiang Power Hospital   (China)

^m FUDAN UNIVERSITY   (China)

ⁿ MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^o FUJIAN MEDICAL UNIVERSITY   (China)

^p SHANDONG UNIVERSITY   (China)

^q HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^r THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^s SICHUAN UNIVERSITY   (China)

^t FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^u GANSU PROVINCIAL HOSPITAL   (China)

^v People's Hospital of Xinjiang Uigur Autonomous Region   (China)

^w GUIZHOU MEDICAL UNIVERSITY   (China)

^x ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

more..

Author keywords

China; GLP 1 receptor agonists; HbA1c; Insulin; Oral antidiabetes drugs (OADs); Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

AGED; ARTICLE; CHINA; CROSS-SECTIONAL STUDY; DRUG ANTAGONISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INJECTION; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; BLOOD GLUCOSE; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS; INSULIN; MALE; MIDDLE AGED; RECEPTORS, GLUCAGON; TREATMENT OUTCOME;

EID: 84879116358     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-602     Document Type: Article

References (18)

1. Shanghai, China, has the lowest confirmed incidence of childhood diabetes in the world. Fu H, Shen SX, Chen ZW, Wang JJ, Ye TT, LaPorte RE, Tajima N, Diabetes Care 1994 17 1206 1208 10.2337/diacare.17.10.1206 7821146 (Pubitemid 24307461)
2. Prevalence of diabetes among men and women in China. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, N Engl J Med 2010 362 1090 1101 10.1056/NEJMoa0908292 20335585
3. Projected and observed diabetes epidemics in China and beyond. Zhao D, Zhao F, Li Y, Zheng Z, Curr Cardiol Rep 2012 14 106 111 10.1007/s11886-011-0227- 9 22057734
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group, Lancet 1998 352 837 853 9742976
5. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials. A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, Diabetes Care 2009 32 187 192 10.2337/dc08-9026 19092168
6. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study Group, Lancet 1998 352 854 865 9742977
7. China guideline for type 2 diabetes. Chinese Diabetes Society, Chin J Diabetes Mellitus 2010 2 suppl 2 6 56
8. Standards of medical care in diabetes-2013. American Diabetes Association, Diabetes Care 2013 36 suppl 1 11 S66 23264422
9. Comprehensive risk assessments of diabetic patients from seven Asian countries: the Joint Asia Diabetes Evaluation (JADE) program. So WY, Raboca J, Sobrepena L, Yoon KH, Deerochanawong C, Ho LT, Himathongkam T, Tong P, Lyubomirsky G, Ko G, Nan H, Chan J, J Diabetes 2011 3 109 118 10.1111/j.1753-0407.2011.00115.x 21599865
10. China's major health challenge: control of chronic diseases. Editorial, Lancet 2011 378 457 10.1016/S0140-6736(11)61232-4 21821170
11. Determinants for inadequate glycaemic control in Chinese patients with mild-to-moderate type 2 diabetes on oral antidiabetic drugs alone. Zhang SL, Chen ZC, Yan L, Chen LH, Cheng H, Ji LN, Chinese Med J (Engl) 2011 124 2461 2468
12. Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS, Endocr Pract 2009 15 540 559 10.4158/EP.15.6.540 19858063
13. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, Diabetes Care 2012 35 1364 1379 10.2337/dc12-0413 22517736
14. Use of anti-diabetic drugs and glycaemic control in type 2 diabetes-The Hong Kong Diabetes Registry. Tong PC, Ko GT, So WY, Chiang SC, Yang X, Kong AP, Ozaki R, Ma RC, Cockram CS, Chow CC, Chan JC, Diabetes Res Clin Pract 2008 82 346 352 10.1016/j.diabres.2008.09.006 18926583
15. Multifaceted determinants for achieving glycemic control: The international diabetes management practice study (IDMPS). Chan JC, Gagliardino JJ, Baik SH, Chantelot JM, Ferrera SR, Hancu N, Ilkova H, Ramchandran A, Aschner P, Diabetes Care 2009 32 227 233 19033410
16. Patients' education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Gagliardino JJ, Aschner P, Baik SH, Chan J, Chantelot JM, Ilkova H, Ramachandran A, Diabetes Metab 2012 38 128 134 10.1016/j.diabet.2011.09.002 22019715
17. US National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health NIH publication no: Diabetes in America, 2nd edition 95 1468 [ http://diabetes.niddk.nih.gov/dm/pubs/america/contents.aspx ]
18. The status of glycemic control: a cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. Bi Y, Zhu D, Cheng J, Zhu Y, Xu N, Cui S, Li W, Cheng X, Wang F, Hu Y, Shen S, Weng J, Clin Ther 2010 32 973 983 10.1016/j.clinthera.2010.05.002 20685506